Kirchner Group Advises Investor in $700M Financing in the BioTech Sector
Kirchner Group is pleased to announce that it acted as an advisor on due diligence to the Alaska Permanent Fund (represented by Crestline Investors) in the recently announced Sana Biotechnology $700M initial financing.
Read Article